Stay informed with the latest litigation news. Explore now
Explore the PTAB proceeding IPR2025-01531 filed by Apotex Inc. on Sep 12, 2025. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Decision pending - set alert to receive updates
The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.
| Document Name | Filing Date | Category | Filing Party |
|---|---|---|---|
Alert me when new update on this case | |||
U.S. Pat. No. 11,344,552 (Bayever) | Sep 12, 2025 | EXHIBIT | PETITIONER |
Expert Declaration of Mark J Ratain MD (IPR2025-00505) | Sep 12, 2025 | EXHIBIT | PETITIONER |
Conroy | Sep 12, 2025 | EXHIBIT | PETITIONER |
Conroy Protocol | Sep 12, 2025 | EXHIBIT | PETITIONER |
Mahaseth | Sep 12, 2025 | EXHIBIT | PETITIONER |
WO 2013/188586 (Bayever) | Sep 12, 2025 | EXHIBIT | PETITIONER |
Saif | Sep 12, 2025 | EXHIBIT | PETITIONER |
Ko | Sep 12, 2025 | EXHIBIT | PETITIONER |
Cantore | Sep 12, 2025 | EXHIBIT | PETITIONER |
Nichetti | Sep 12, 2025 | EXHIBIT | PETITIONER |
Nevala-Plagemann | Sep 12, 2025 | EXHIBIT | PETITIONER |
Masi | Sep 12, 2025 | EXHIBIT | PETITIONER |
Carnevale | Sep 12, 2025 | EXHIBIT | PETITIONER |
Dean | Sep 12, 2025 | EXHIBIT | PETITIONER |
PCT/US2016/047727 (Bayever) | Sep 12, 2025 | EXHIBIT | PETITIONER |
Ginocchi | Sep 12, 2025 | EXHIBIT | PETITIONER |
Conroy - Supplementary Appendix | Sep 12, 2025 | EXHIBIT | PETITIONER |
Wainberg | Sep 12, 2025 | EXHIBIT | PETITIONER |
Wainberg (2021) | Sep 12, 2025 | EXHIBIT | PETITIONER |
U.S. Pat. App. Pub. 2017/0049775 (Bayever) | Sep 12, 2025 | EXHIBIT | PETITIONER |
Hatachi | Sep 12, 2025 | EXHIBIT | PETITIONER |
Zaniboni | Sep 12, 2025 | EXHIBIT | PETITIONER |
Tsai | Sep 12, 2025 | EXHIBIT | PETITIONER |
U.S. Pat. No. 8,147,867 (Hong) | Sep 12, 2025 | EXHIBIT | PETITIONER |
Merrimack Pharm. MM-398 | Sep 12, 2025 | EXHIBIT | PETITIONER |
WO 2016/094402 (Bayever) | Sep 12, 2025 | EXHIBIT | PETITIONER |
Alcindor | Sep 12, 2025 | EXHIBIT | PETITIONER |
PCT/US2016/047727 (Bayever) | Sep 12, 2025 | EXHIBIT | PETITIONER |
PCT/US2016/047727 (Bayever) | Sep 12, 2025 | EXHIBIT | PETITIONER |
PCT/US2016/047727 (Bayever) | Sep 12, 2025 | EXHIBIT | PETITIONER |
PCT/US2016/047727 (Bayever) | Sep 12, 2025 | EXHIBIT | PETITIONER |
PCT/US2016/047727 (Bayever) | Sep 12, 2025 | EXHIBIT | PETITIONER |
Leucovorin Calcium Injections USP (Bedford Labs.) | Sep 12, 2025 | EXHIBIT | PETITIONER |
Highlights of Prescribing Information - Gemcitabine | Sep 12, 2025 | EXHIBIT | PETITIONER |
Highlights of Prescribing Information - Abraxane | Sep 12, 2025 | EXHIBIT | PETITIONER |
Xeloda (capecitabine) - label | Sep 12, 2025 | EXHIBIT | PETITIONER |
Xeloda (capecitabine) - label | Sep 12, 2025 | EXHIBIT | PETITIONER |
Highlights of Prescribing Information - Eloxatin (oxaliplatin) | Sep 12, 2025 | EXHIBIT | PETITIONER |
Highlights of Prescribing Information - Tarceva (erlotinib) | Sep 12, 2025 | EXHIBIT | PETITIONER |
Product Monograph - Fluorouracil Injection (Sandoz Canada) | Sep 12, 2025 | EXHIBIT | PETITIONER |
Conroy (2013) | Sep 12, 2025 | EXHIBIT | PETITIONER |
Ko | Sep 12, 2025 | EXHIBIT | PETITIONER |
Blazer | Sep 12, 2025 | EXHIBIT | PETITIONER |
Alessandretti | Sep 12, 2025 | EXHIBIT | PETITIONER |
Paller | Sep 12, 2025 | EXHIBIT | PETITIONER |
Hamberg | Sep 12, 2025 | EXHIBIT | PETITIONER |
Hess | Sep 12, 2025 | EXHIBIT | PETITIONER |
Goel | Sep 12, 2025 | EXHIBIT | PETITIONER |
Rachamalla | Sep 12, 2025 | EXHIBIT | PETITIONER |
Wildiers | Sep 12, 2025 | EXHIBIT | PETITIONER |
Gajra | Sep 12, 2025 | EXHIBIT | PETITIONER |
Shayne | Sep 12, 2025 | EXHIBIT | PETITIONER |
Sharma | Sep 12, 2025 | EXHIBIT | PETITIONER |
Chang | Sep 12, 2025 | EXHIBIT | PETITIONER |
Roy | Sep 12, 2025 | EXHIBIT | PETITIONER |
Slingerland | Sep 12, 2025 | EXHIBIT | PETITIONER |
Chen | Sep 12, 2025 | EXHIBIT | PETITIONER |
Kim | Sep 12, 2025 | EXHIBIT | PETITIONER |
Hann | Sep 12, 2025 | EXHIBIT | PETITIONER |
PCT/US2016/047727 (Bayever) | Sep 12, 2025 | EXHIBIT | PETITIONER |
National Cancer Institute (2015) | Sep 12, 2025 | EXHIBIT | PETITIONER |
File Wrapper U.S. Pat. No. 11,344,552 (Bayever) | Sep 12, 2025 | EXHIBIT | PETITIONER |
ClinicalTrials.gov archive - NCT01523457 | Sep 12, 2025 | EXHIBIT | PETITIONER |
Recommended Dose Modifications for Camptosar/5-Fluorouracil (5-FU) | Sep 12, 2025 | EXHIBIT | PETITIONER |
Office Action U.S. Pat. App. No. 15/227,561 | Sep 12, 2025 | EXHIBIT | PETITIONER |
Office Action U.S. Pat. App. No. 15/809,815 | Sep 12, 2025 | EXHIBIT | PETITIONER |
PCT/EP2012/057542 International Search Report | Sep 12, 2025 | EXHIBIT | PETITIONER |
Infante | Sep 12, 2025 | EXHIBIT | PETITIONER |
NCCN Clinical Practice Guideline - Pancreatic Adenocarcinoma | Sep 12, 2025 | EXHIBIT | PETITIONER |
WO 03/101474 (Alvarez) | Sep 12, 2025 | EXHIBIT | PETITIONER |
WO 2012/079582 (Petersen) | Sep 12, 2025 | EXHIBIT | PETITIONER |
WO 2017/031445 - PCT/US2016/047827 Combination Therapy for Cancer Treatment | Sep 12, 2025 | EXHIBIT | PETITIONER |
Hayashi | Sep 12, 2025 | EXHIBIT | PETITIONER |
Miles | Sep 12, 2025 | EXHIBIT | PETITIONER |
U.S. Pat. App. 15/809,815 Detailed Action | Sep 12, 2025 | EXHIBIT | PETITIONER |
Gounaris | Sep 12, 2025 | EXHIBIT | PETITIONER |
Chin | Sep 12, 2025 | EXHIBIT | PETITIONER |
Wang-Gillam | Sep 12, 2025 | EXHIBIT | PETITIONER |
Picozzi | Sep 12, 2025 | EXHIBIT | PETITIONER |
NCCN Clinical Practice Guidelines - Pancreatic Adenocarcinoma (2.2012) | Sep 12, 2025 | EXHIBIT | PETITIONER |
Latimer | Sep 12, 2025 | EXHIBIT | PETITIONER |
WO 02/02077 - PCT/CA01/000925 Liposomal Antineoplastic Drugs | Sep 12, 2025 | EXHIBIT | PETITIONER |
CN 1980637 B | Sep 12, 2025 | EXHIBIT | PETITIONER |
WO 2010/125462 - PCT/IB2010/001012 Pentamidine Combinations for Treating | Sep 12, 2025 | EXHIBIT | PETITIONER |
WO 2017/172678 (Fitzgerald) | Sep 12, 2025 | EXHIBIT | PETITIONER |
WO 2005/107712 - PCT/US2005/015349 | Sep 12, 2025 | EXHIBIT | PETITIONER |
Batist | Sep 12, 2025 | EXHIBIT | PETITIONER |
Lundberg | Sep 12, 2025 | EXHIBIT | PETITIONER |
Park | Sep 12, 2025 | EXHIBIT | PETITIONER |
Schroen | Sep 12, 2025 | EXHIBIT | PETITIONER |
Wulaningsih | Sep 12, 2025 | EXHIBIT | PETITIONER |
U.S. Pat. App. No. 15/809815 (Bayever) - Elec. Acknowledgement Receipt | Sep 12, 2025 | EXHIBIT | PETITIONER |
Emerson | Sep 12, 2025 | EXHIBIT | PETITIONER |
Falcone | Sep 12, 2025 | EXHIBIT | PETITIONER |
Chapter 2 - Materials and Methods | Sep 12, 2025 | EXHIBIT | PETITIONER |
Kalra | Sep 12, 2025 | EXHIBIT | PETITIONER |
U.S. Pat. App. No. 15/809815(Bayever) - Elec. Acknowledgement Receipt | Sep 12, 2025 | EXHIBIT | PETITIONER |
Tsai | Sep 12, 2025 | EXHIBIT | PETITIONER |
Expert Declaration - Grant H. Castle Ph.D. (EP2861210) | Sep 12, 2025 | EXHIBIT | PETITIONER |
Chen | Sep 12, 2025 | EXHIBIT | PETITIONER |
Russo | Sep 12, 2025 | EXHIBIT | PETITIONER |
Petition: as filed | Sep 12, 2025 | PAPER | PETITIONER |
Expert Declaration of Robert Dreicer | Sep 12, 2025 | EXHIBIT | PETITIONER |
Notice: Power of Attorney | Sep 12, 2025 | PAPER | PETITIONER |
Apotex's Motion for Joinder to Inter Partes Review of IPR2025-00505 | Sep 12, 2025 | PAPER | PETITIONER |